References
- Cabanes J, Chazarra S, Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase. J Pharm Pharmacol 1994;46:982–985.
- Yoshimura M, Watanabe Y, Kasai K, Yamakoshi J, Koga T. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci Biotechnol Biochem 2005;69:2368–2373.
- Maeda K, Fukuda M. Arbutin: Mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 1996;276:765–769.
- Sánchez-Ferrer A, Rodríguez-López JN, García-Cánovas F, García-Carmona F. Tyrosinase: A comprehensive review of its mechanism. Biochim Biophys Acta 1995;1247:1–11.
- Körner M, Pawelek J. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 1982;217:1163–1165.
- Funayama M, Arakawa H, Yamamoto R, Nishino T, Shin T, Murao S. Effects of alpha-and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma. Biosci Biotechnol Biochem 1995;59:143–144.
- Kim Y, Uyama H. Tyrosinase inhibitors from natural and synthetic sources: Structure, inhibition mechanism and perspective for the future. Cell Mol Life Sci 2005;62:1707–1723.
- Kim SJ, Jung SH, Cho CW. Physicochemical studies of a newly synthesized molecule, 6-methyl-3-phenethyl-3,4-dihydro-1H-quinazoline-2-thione (JSH18) for topical formulations. Arch Pharm Res 2008; 31:1363–1368.
- Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54(Suppl. 1):S131.
- Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001;47:165.
- Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetics and dermatological preparations. Adv Drug Del Rev 2002;54:S131–155.
- Tiyaboonchai W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. J Pharmacol 2007;337:299–306.
- Weyenberg W, Plamen Filev P, Vandervoort J. Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. Int J Pharm 2007;337:291–298.
- Kobayash S. UVB-induced skin damage and the protection/ treatment effects of a novel, hydrophilic r-tocopherol derivative. Yakugaku Zasshi 2006;126:677–693.